Biosynthetic Gas Vesicles Combined with Focused Ultrasound for Blood–Brain Barrier Opening
Jinghan Zhang,Fei Yan,Wei Zhang,Lei He,Yi Li,Shuai Zheng,Yuanyuan Wang,Tengfei Yu,Lijuan Du,Yuanyuan Shen,Wen He
DOI: https://doi.org/10.2147/ijn.s374039
IF: 7.033
2022-12-28
International Journal of Nanomedicine
Abstract:Jinghan Zhang, 1 Fei Yan, 2 Wei Zhang, 1 Lei He, 1 Yi Li, 3 Shuai Zheng, 1 Yuanyuan Wang, 4 Tengfei Yu, 1 Lijuan Du, 1 Yuanyuan Shen, 5 Wen He 1 1 Department of Ultrasound, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China; 2 Center for Cell and Gene Circuit Design, CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People's Republic of China; 3 Department of Radiology, Peking Union Medical College Hospital, Beijing, People's Republic of China; 4 Department of Ultrasound, The Second Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China; 5 National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Bio Medical Engineering, Health Science Center, Shenzhen University, Shenzhen, People's Republic of China Correspondence: Yuanyuan Shen; Wen He, Email ; Background: Focused ultrasound (FUS) combined with microbubbles (MBs) has emerged as a potential approach for opening the blood–brain barrier (BBB) for delivering drugs into the brain. However, MBs range in size of microns and thus can hardly extravasate into the brain parenchyma. Recently, growing attention has been paid to gas vesicles (GVs), which are genetically encoded gas-filled nanostructures with protein shells, due to their potential for extravascular targeting in ultrasound imaging and therapy. However, the use of GVs as agents for BBB opening has not yet been investigated. Methods: In this study, GVs were extracted and purified from Halobacterium NRC-1 . Ultrasound imaging performance of GVs was assessed in vitro and in vivo. Then, FUS/GVs-mediated BBB opening for small molecular Evans blue or large molecular liposome delivery across the BBB was examined. Results: The results showed a good contrast performance of GVs for brain perfusion ultrasound imaging in vivo. At the acoustic negative pressure of 1.5 MPa, FUS/GVs opened the BBB safely, and effectively enhanced Evans blue and 200-nm liposome delivery into the brain parenchyma. Conclusion: Our study suggests that biosynthetic GVs hold great potential to serve as local BBB-opening agents in the development of new targeted drug delivery strategies for central nervous system disorders. Keywords: gas vesicles, blood–brain barrier, focused ultrasound, drug delivery, nanoparticles The blood–brain barrier (BBB) plays a vital role in maintaining the homeostasis of the central nervous system (CNS) by protecting brain tissue from pathogens and toxic substances from the blood. 1,2 However, it also limits the ability of all large-molecule therapeutics and over 98% of small-molecule drugs to reach the brain. 3 Consequently, it is important to tackle the efficient administration of drugs into the brain without affecting the normal structure and function of BBB. Extensive preclinical and clinical studies have demonstrated the outstanding capability of focused ultrasound combined with systemically circulating microbubbles (FUS/MBs) to enhance macromolecular delivery to the brain across BBB temporarily, noninvasively, and reversibly. 4–11 This approach has tremendous potential for enhancing the delivery of chemotherapeutic drugs, 4–6 antibodies, 6,7 genes, 8,9 and cells. 10,11 However, MBs range in size of microns and thus can hardly extravasate into the extravascular compartment, leading to limitations in potential therapeutic applications. 12,13 Recently, there has been growing attention paid to agents with smaller sizes to extend FUS-mediated applications beyond that of the larger MB counterparts. Gas vesicles (GVs) are nanoscale biconical cylinders with a width of 45–250 nm and a length of 100–600 nm, 14 and they are formed by some prokaryotic cells in lakes and oceans to regulate their buoyancy for harvesting light. Structurally, they have a thin (~2 nm) protein shell that is hydrophobic on the inner surface and hydrophilic on the outer surface. 14–17 This special structure allows GVs to exclude water but to make gas exchange through the protein shell, endowing them with robust physical stability. 14,18 An increasing number of studies have shown that GVs may be an acoustic contrast agent with great potential for ultrasound imaging and therapeutic applications. 14,16,18,20–24 The submicron size of GVs considerably expands their potential range to extravascular and intracellular targets. 19 Aside from being a reporte -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology